Figlin RA - Search Results

1

Atypical contrast reactions associated with systemic interleukin-2 therapy.

Fishman JE, Aberle DR, Moldawer NP, Belldegrun A, Figlin RA. Fishman JE, et al. Among authors: figlin ra. AJR Am J Roentgenol. 1991 Apr;156(4):833-4. doi: 10.2214/ajr.156.4.2003450. AJR Am J Roentgenol. 1991. PMID: 2003450 No abstract available.

2

Metastatic renal cell cancer: interleukin-2 toxicity induced by contrast agent injection.

Abi-Aad AS, Figlin RA, Belldegrun A, deKernion JB. Abi-Aad AS, et al. Among authors: figlin ra. J Immunother (1991). 1991 Aug;10(4):292-5. J Immunother (1991). 1991. PMID: 1931865

3

Interferon-alpha primed tumor-infiltrating lymphocytes combined with interleukin-2 and interferon-alpha as therapy for metastatic renal cell carcinoma.

Belldegrun A, Pierce W, Kaboo R, Tso CL, Shau H, Turcillo P, Moldawer N, Golub S, deKernion J, Figlin R. Belldegrun A, et al. J Urol. 1993 Nov;150(5 Pt 1):1384-90. doi: 10.1016/s0022-5347(17)35785-3. J Urol. 1993. PMID: 8411405 Clinical Trial.

4

Renal cell carcinoma: basic biology and clinical behavior.

Franklin JR, Figlin R, Belldegrun A. Franklin JR, et al. Semin Urol Oncol. 1996 Nov;14(4):208-15. Semin Urol Oncol. 1996. PMID: 8946619 Review.

5

Cellular therapy: scientific rationale and clinical results in the treatment of metastatic renal-cell carcinoma.

Pierce WC, Belldegrun A, Figlin RA. Pierce WC, et al. Among authors: figlin ra. Semin Oncol. 1995 Feb;22(1):74-80. Semin Oncol. 1995. PMID: 7855622 Review. No abstract available.

6

Combination biologic therapy with interleukin-2 and interferon-alfa in the outpatient treatment of metastatic renal cell carcinoma.

Figlin RA, Pierce WC, Belldegrun A. Figlin RA, et al. Semin Oncol. 1993 Dec;20(6 Suppl 9):11-5. Semin Oncol. 1993. PMID: 8284686 Review. No abstract available.

7

Soluble tumor necrosis factor receptor expression in patients with metastatic renal cell carcinoma treated with interleukin-2-based immunotherapy.

Belldegrun A, Pierce W, Sayah D, deKernion J, Wallach D, Aderka D, Figlin RA. Belldegrun A, et al. Among authors: figlin ra. J Immunother Emphasis Tumor Immunol. 1993 Apr;13(3):175-80. doi: 10.1097/00002371-199304000-00004. J Immunother Emphasis Tumor Immunol. 1993. PMID: 8385988

8

Treatment of metastatic renal cell carcinoma with nephrectomy, interleukin-2 and cytokine-primed or CD8(+) selected tumor infiltrating lymphocytes from primary tumor.

Figlin RA, Pierce WC, Kaboo R, Tso CL, Moldawer N, Gitlitz B, deKernion J, Belldegrun A. Figlin RA, et al. J Urol. 1997 Sep;158(3 Pt 1):740-5. doi: 10.1097/00005392-199709000-00012. J Urol. 1997. PMID: 9258071 Clinical Trial.

9

Expanding the indications for surgery and adjuvant interleukin-2-based immunotherapy in patients with advanced renal cell carcinoma.

Belldegrun A, Shvarts O, Figlin RA. Belldegrun A, et al. Among authors: figlin ra. Cancer J Sci Am. 2000 Feb;6 Suppl 1:S88-92. Cancer J Sci Am. 2000. PMID: 10685666

10

Immune gene therapy for kidney cancer: the search for a magic trigger.

Kim HL, Belldegrun AS, Figlin RA. Kim HL, et al. Among authors: figlin ra. Mol Ther. 2003 Feb;7(2):153-4. doi: 10.1016/s1525-0016(02)00048-5. Mol Ther. 2003. PMID: 12597902 Free article. Review. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

379 results

Search Page

Filters